Salicylates News and Research

RSS
Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK

Gout: An Interview with Dr. Lawrence Edwards, Chairman and CEO of GUAES

Gout: An Interview with Dr. Lawrence Edwards, Chairman and CEO of GUAES

Simple urine test picks up mesalamine non-adherence

Simple urine test picks up mesalamine non-adherence

New evidence helps explain additional health benefits of aspirin

New evidence helps explain additional health benefits of aspirin

Top-line results from Shire's SPD476 phase 3 trial on diverticulitis

Top-line results from Shire's SPD476 phase 3 trial on diverticulitis

ADHD diet: Review of studies

ADHD diet: Review of studies

FDA approves Shire's Lialda for maintenance of remission of ulcerative colitis

FDA approves Shire's Lialda for maintenance of remission of ulcerative colitis

Conference reviews recent evidence that links aspirin use with reduced risk of several cancers

Conference reviews recent evidence that links aspirin use with reduced risk of several cancers

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

American Regent initiates voluntary recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%

American Regent initiates voluntary recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone

Catabasis Pharmaceuticals to advance program targeting type 2 diabetes with $39.6 million Series A financing

Catabasis Pharmaceuticals to advance program targeting type 2 diabetes with $39.6 million Series A financing

Shire reports results of Lialda and 5-ASA persistency analyses

Shire reports results of Lialda and 5-ASA persistency analyses

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Muscle rubs for pain in adults – no evidence they work

Muscle rubs for pain in adults – no evidence they work

Aspirin-like compounds (salicylates) increase insulin secretion in otherwise healthy obese people

Aspirin-like compounds (salicylates) increase insulin secretion in otherwise healthy obese people

Poison prevention starts with respecting, inspecting medicines

Poison prevention starts with respecting, inspecting medicines